HIV/AIDS Pharmaceutical Company News

J&J Will Not Join Medicines Patent Pool; Company's Pharma Head Says Mechanism Could "Cause Disaster" (January 3, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
BMS Selects 2011 "Fight HIV Your Way" Contest Winners (August 15, 2011)
From Bristol-Myers Squibb Company
Gilead Under Investigation Over Manufacture of Drugs (June 13, 2011)
In Pharma Times
Bloomberg Reports on Challenges of Bringing New HIV Drugs to Market (March 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Bloomberg BusinessWeek Explores Growing Trend in Pharma to License, Donate HIV Drugs (August 6, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
GSK and Pfizer Combine HIV Efforts Into a New Company: ViiV Healthcare (January/February 2010)
In Positively Aware, from Test Positive Aware Network
ATAC's Drug Company "Report Card" (February 2010)
To read PDF, click here.
From Project Inform
Merck Reps Banned From U.S. AIDS Clinics Over Drug Costs (January 29, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
GlaxoSmithKline, Pfizer Formally Launch Company to Develop New HIV Treatments (November 3, 2009)
Two of the major pharmaceutical companies producing HIV meds have launched a new joint company focused solely on HIV: ViiV Healthcare.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS (September 10, 2009)
From AIDS Treatment Activists Coalition
HIV/AIDS Activists Give Harsh Grades to Drug Companies (September 10, 2009)
In HIV News & Views, from The Body
AIDS Treatment Activist Milestones/Accomplishments (September 10, 2009)
To read PDF, click here.
From AIDS Treatment Activists Coalition
Report Card Research Background: Pharmaceutical Company HIV/AIDS Report Card -- Research Methodology and Scoring (September 10, 2009)
From AIDS Treatment Activists Coalition
Report Card Recommendations: 10 Steps to Corporate Social Responsibility (September 10, 2009)
From AIDS Treatment Activists Coalition
Most Pharmaceutical Companies Receive Poor Grades on HIV/AIDS Drug Development Innovation, According to AIDS Treatment Activist Coalition Report Card (September 10, 2009)
Many companies get low marks in five benchmark treatment categories; new drugs need to reflect long-term care strategy.
To read PDF, click here.
From AIDS Treatment Activists Coalition
Major Drug Firms Will Combine to Form a Single HIV Drug Company (April 16, 2009)
GlaxoSmithKline and Pfizer, two major drug companies that produce 11 HIV meds between them, will form a new company by year's end that will devote itself entirely to HIV, and will combine the two parent companies' HIV marketing, distribution, research and drug pipelines.
In The New York Times
GSK, Pfizer Announce Combined HIV/AIDS Drug Business (April 16, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
As Drug Companies Fund the Fight Against HIV, Who's Watching the Drug Companies? (April 2009)
In this interview, longtime HIV advocate Mike Barr offers some insight into the complicated relationship between the HIV community and HIV drug companies.
From Frontiers in L.A.
Roche to Stop Antiretroviral Research, Company Says (July 14, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Some Doctors Say No to Drug Company Money (April 15, 2008)
In The New York Times
Gilead Sciences May Lose Patent for Viread (January 25, 2008)
Looser patent laws could mean generic version of Tenofovir to come.
In Housing Works AIDS Issues Update, from Housing Works
Bristol-Myers Slammed By AIDS Group Over Pricing (January 16, 2008)
From Pharmalot
GlaxoSmithKline Withdraws Patent Applications for Antiretrovirals Abacavir, Trizivir in India (December 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
As HIV Meds Fight the Virus, Drug Companies Duel Over Profits (November 19, 2007)
From CNNMoney.com
Trimeris Shares Increase 13% as Sales of Fuzeon Rise in Europe, Brazil; Analysts Predict Profit as Early as 2006 (July 22, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Gilead's Second-Quarter Profits Rise 76% Because of 61% Increase in Antiretroviral Sales (July 21, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine (July 19, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Who Provides You With Up-to-Date Treatment Information? (December 2004)
A brief review of popular HIV treatment information resources and their reliance on pharmaceutical funding.
In TAGline, from Treatment Action Group
Pfizer Announces New Initiative to Expand Access to Its Prescription Drugs (July 9, 2004)
"Helpful Answers" focuses on providing drug discounts to uninsured Americans.
In AIDS Action Weekly Update, from AIDS Action Council
European Patients Lobby European Commission to Ease Its Ban on Drug Ads (April 30, 2004)
[Archived Article]
In The Wall Street Journal
Gilead Sciences First-Quarter Profits Driven by Increase in Sales of Antiretroviral Viread (April 26, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
AIDS Healthcare Foundation Asks FDA to Withdraw Approval of GSK's Antiretroviral Drug Trizivir (August 20, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
FDA Orders Gilead for Second Time to Stop Downplaying Risks, Inflating Benefits of Antiretroviral Drug Viread (August 8, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
States, Territories Negotiate $65M in Annual Price Concessions for HIV/AIDS Drugs From Eight Pharmaceutical Companies (August 6, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Lack of Demand Forcing Indian Pharmaceutical Companies to Shift Production From Antiretrovirals to Other Drugs (March 19, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Global Treatment Update (December 2002)
Gilead strikes a deal with Africa on tenofovir; a new handbook for orgs looking to provide treatment.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug (October 15, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
San Francisco: Supervisors President Ammiano and City Attorney Herrera Take on HIV Drug Ads (May 31, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention